Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Am J Obstet Gynecol. 2013 May 6;209(3):244.e1–244.e9. doi: 10.1016/j.ajog.2013.05.008

Figure 2. Percent of participants taking 4mg, 8mg, a combination of 4mg and 8mg, and no medication at each time-point during the open label follow-up study.

Figure 2